Skip to content

The Effect of Rectus Muscle Approximation at Cesarean Delivery on Pain Perceived After Operation

The Effect of Rectus Muscle Approximation at Cesarean Delivery on Postoperative Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03306953
Enrollment
280
Registered
2017-10-11
Start date
2017-10-11
Completion date
2018-01-20
Last updated
2018-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative

Brief summary

This is a prospective randomized controlled study to determine the clinical outcome of rectus muscle re-approximation at Cesarean delivery.

Detailed description

This is a prospective randomized controlled study to determine the clinical outcome of rectus muscle re-approximation at Cesarean delivery. Postoperative pain will be assessed in 2 groups. Rectus muscle approximation will be done to the first group. The second group will be the control group.

Interventions

The surgeon will take sutures to approximate rectus muscles at the end of cesarean delivery.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

* Women who will undergo first elective cesarean section * Singleton pregnancy

Exclusion criteria

* Previous abdominal or pelvic surgery * Medical or psychiatric disease * Previous pelvic inflammatory disease * Obesity * Allergy to analgesics

Design outcomes

Primary

MeasureTime frameDescription
Early pain score24 hours after cesarean sectionEarly pain score will be assessed by an investigator for patients

Secondary

MeasureTime frameDescription
Late pain score48 hours after cesarean sectionLate pain score will be assessed by an investigator for patients

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026